14
Jul
09

UPDATE 1-Glaxo investing $97 mln in AIDS drugs for Africa

 

From Reuters.com

LONDON, July 14 (Reuters) – GlaxoSmithKline (GSK.L) plans to invest up to 60 million pounds ($97 million) over 10 years to improve research, development and access to AIDS drugs in Africa, the world’s second biggest drugmaker said on Tuesday.

It has also agreed a new free voluntary licensing agreement for AIDS drug abacavir, or Ziagen, with South African generic drugmaker Aspen Pharmacare (APNJ.J), in which it has a 16 percent stake. Aspen will manufacture a cheaper generic version of the drug.

The latest steps, announced by Glaxo Chief Executive Andrew Witty on a visit to Kenya, follow pressure from campaigners and some governments for drug companies to do more to get life-saving medicines to the poor, particularly in sub-Saharan Africa.

Glaxo took a lead in February by promising to place many of its patents on drugs for tropical diseases into a free “pool”, but it stopped short of offering patents on medicines for HIV/AIDS, which it does not consider to be a neglected disease.

“Up until now I’ve not really seen the articulation of how a patent pool in this particular area (HIV/AIDS) would change things dramatically,” Witty told reporters in conference call.

“The patent pool on neglected diseases was because there was really no research going on in that area — HIV is not a neglected disease.”

So far Glaxo is the only big drug company to have committed to pool some of drug patents, although it was joined in the initiative last week by U.S. biotech Alnylam Pharmaceuticals (ALNY.O). Glaxo hopes others will follow suit. Its new investments will see up to 50 million pounds channelled into a fund to support non-governmental organisations working with pregnant women to prevent mother-to-child transmission of HIV.

A further 10 million pounds in seed funding will go to support public-private partnership work in developing AIDS medicines specifically for children. ($1=.6147 pounds) (Reporting by Ben Hirschler; Editing by Greg Mahlich)

Advertisements

1 Response to “UPDATE 1-Glaxo investing $97 mln in AIDS drugs for Africa”



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Follow Danny on Twitter!!

Prevention Education Stats

  • 5,175 hits

%d bloggers like this: